Medical News

RSS

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.

27 Jun 2014

Research shows colon cancer survivors are more likely to experience pain in back, abdomen

Researchers from the University of Granada have discovered that colon cancer survivors are more likely to suffer future lesions related with pain in the back and lower abdomen than healthy individuals of the same gender and age.

27 Jun 2014

HHS says marketplace customers can automatically renew their plans

The announcement says people getting subsidies will be allowed to renew for 2015 without filing an application or going back on healthcare.gov. But consumer advocates caution that may not be the best option for those customers.

27 Jun 2014

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.

27 Jun 2014

Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

Noroviruses are a leading cause of acute gastroenteritis (diarrhoea and vomiting) across all age groups, responsible for almost a fifth (18%) of all cases worldwide. New estimates, published in The Lancet Infectious Diseases, highlight the importance of developing norovirus vaccines, say the authors.

27 Jun 2014

FDA clears ReWalk wearable robotic exoskeleton for home usage

Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.

27 Jun 2014

China Biologic prices follow-on offering of common stock at $38.00 per share

China Biologic Products, Inc., a leading plasma-based biopharmaceutical company in China, today announced the pricing of a follow-on offering of 1,550,000 shares of common stock at a public offering price of $38.00 per share.

27 Jun 2014

Thoratec commences CE Mark Clinical Trial for HeartMate III chronic left ventricular assist system

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE Mark Clinical Trial for HeartMate III™ commenced with the first patient implanted with this new device.

27 Jun 2014

High-risk surgery patients who visit primary care physician have lower risk of hospital readmissions

Patients who have post-operative complications following high-risk surgery have a significantly lower risk of being readmitted to the hospital within 30 days if they go see their primary care physician soon following discharge, a new study in JAMA Surgery shows.

27 Jun 2014

Research roundup: Role of primary care in reducing readmissions; air transport for wounded soldiers; hospital prices

Follow-up with a primary care provider (PCP) in addition to the surgical team is routinely recommended to patients discharged after major surgery despite no clear evidence that it improves outcomes.

27 Jun 2014

Non-Hodgkin lymphoma subgroups found to have different survival rates

A Mayo Clinic-led group of researchers has discovered three subgroups of a single type of non-Hodgkin lymphoma that have markedly different survival rates. These subgroups could not be differentiated by routine pathology but only with the aid of novel genetic tests, which the research team recommends giving to all patients with ALK-negative anaplastic large-cell lymphoma (ALCL). Findings are published in the journal Blood.

27 Jun 2014

WHO convenes experts for operational response to 2014 Ebola outbreak in West Africa

The emergence of an Ebola virus disease outbreak in West Africa in 2014 has become a challenge to the 3 countries involved, as the Governments of Guinea, Liberia and Sierra Leone work intensively with WHO and other partners to ramp up a series of measures to control the outbreak.

27 Jun 2014

University of Utah researcher to receive Nelson Trust Award for Retinitis Pigmentosa

Research to Prevent Blindness, a New York-based foundation, has announced that University of Utah researcher Wolfgang Baehr, Ph.D., will receive the Nelson Trust Award for Retinitis Pigmentosa-and an accompanying $100,000 to pursue new scientific leads to understand contributors to blindness.

27 Jun 2014

Viewpoints: ObamaCare and economic growth; involving judiciary in political disputes

Financial markets shrugged off Wednesday's punch-in-the-stomach report that first quarter GDP shrank by 2.9% on an annual basis, far more than earlier estimates and the worst quarterly decline in five years. Optimists blame the weather and point to faster growth in the current quarter, which is reasonable but still shouldn't overlook ObamaCare's role in nearly sending the economy back into recession.

27 Jun 2014

Dosing commences in Essentialis’ DCCR clinical study in obese Prader-Willi syndrome patients

Essentialis announced today the dosing of the first patient in clinical study PC025, which is designed to evaluate the safety and efficacy of diazoxide choline controlled release tablets (DCCR) in obese Prader-Willi syndrome patients.

27 Jun 2014

First Edition: June 27, 2014

Today's early morning highlights from the major news organizations, including reports on an HHS announcement detailing some of the marketplace enrollment plans for next fall.

27 Jun 2014

FDA grants Encision 510(k) approval for AEM Endoshield Burn Protection System

Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has received FDA 510(k) premarket notification approval for its AEM Endoshield™ Burn Protection System ("EndoShield").

27 Jun 2014

Medical News

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Research shows colon cancer survivors are more likely to experience pain in back, abdomen

HHS says marketplace customers can automatically renew their plans

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Noroviruses responsible for almost a fifth of all cases of acute gastroenteritis

FDA clears ReWalk wearable robotic exoskeleton for home usage

China Biologic prices follow-on offering of common stock at $38.00 per share

Thoratec commences CE Mark Clinical Trial for HeartMate III chronic left ventricular assist system

High-risk surgery patients who visit primary care physician have lower risk of hospital readmissions

Research roundup: Role of primary care in reducing readmissions; air transport for wounded soldiers; hospital prices

Non-Hodgkin lymphoma subgroups found to have different survival rates

WHO convenes experts for operational response to 2014 Ebola outbreak in West Africa

University of Utah researcher to receive Nelson Trust Award for Retinitis Pigmentosa

Viewpoints: ObamaCare and economic growth; involving judiciary in political disputes

Dosing commences in Essentialis’ DCCR clinical study in obese Prader-Willi syndrome patients

First Edition: June 27, 2014

FDA grants Encision 510(k) approval for AEM Endoshield Burn Protection System

Va. GOP lawmakers detail legal strategy on any efforts by governor to expand Medicaid

USA Today: Mental health system is 'in shambles'

Turmoil at VA continues as two more senior officials resign

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News